Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Kirsten Parratt (Fed)
Biomedical Engineer
OVERVIEW
Kirsten Parratt, PhD is a Biomedical Engineer in the Biomaterials Group. She works to improve the quantitation and characterization of microbial populations to support biomanufacturing industries such as Live Biotherapeutic Products (live microbial therapeutics) and Rapid Microbial Testing Methods for advanced therapy products. For example, currently she is developing multiplexed flow cytometry assays to measure the activity, viability, and health of microbial cell populations. Previously she was a NIST-NRC Postdoctoral Research Associate mentored by Nancy J. Lin. The goal of her NRC work was to develop quantitative measurements of adherent microbial communities and biofilm-material interactions. Her graduate dissertation research focused on using flow cytometry as a high-throughput and high replicate platform to assay microfabricated biomaterials for stem cell differentiation studies and detection applications.
Research interests:
- Microbial flow cytometry
- Microbial cell health measurements
- Rapid Microbial Testing Methods
- Quantification of microbial biofilms
- Biofilm-material interactions, cell-material interactions
PUBLICATIONS
- Parratt, K.; Jeong, J.; Qiu, P.; Roy, K. 3D Material Cytometry (3DMaC): A Very High-replicate, High-throughput Analytical Method using Microfabricated, Shape-specific, Cell-material Niches. Lab on a Chip, 2017, 17, 2861-2872.
- Parratt, K.; Smerchansky, M.; Stiggers, Q.; Roy, K. Effect of Hydrogel Material Composition on hBMSC Differentiation into Zone-specific Neo-cartilage: Engineering Human Articular Cartilage with Spatially Varying Properties. Journal of Materials Chemistry B, 2017, 5, 6237-6248.
- Dwarshuis, N.; Parratt, K.; Santiago-Miranda, A.; Roy, K. Cells as Advanced Therapeutics: State-of-the-art, Challenges, and Opportunities in Large Scale Biomanufacturing of High-Quality Cells for Adoptive Immunotherapies. Advanced Drug Delivery Reviews, 2017, 114, 222-239.